More than 1,300 women to get breakthrough cancer drug

The treatment – for the aggressive HER2+ form of the disease – extends life for women dying with breast cancer by an average 56 months, 16 months more than the next best treatment.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news